MedTech Innovator selects 65 startups for its 2024 cohort

31 May 2024
www.medicaldesignandoutsourcing.com
More than five dozen medical device, diagnostic, and digital health startups have been selected for the 2024 MedTech Innovator accelerator program. The startups include two companies interviewed by Medical Design & Outsourcing in the past year: Flow Medical and The Shape Sensing Co. “Our accelerator has become the gold standard, thanks to our industry-leading track record of identifying and refining the most innovative medtech startups in the world,” MedTech Innovator founder and CEO Paul Grand said in a news release. “Since launching MedTech Innovator, our more than 600 graduates have received 310 FDA approvals and clearances and secured $8 billion in follow-on funding.” Approximately 1,300 startups applied for this year’s program. Major medtech firms including Asahi Intecc, BD, Dexcom, Edwards Lifesciences, Johnson & Johnson, NIPRO, Olympus, W. L. Gore & Associates and Zimmer Biomet helped narrow the pool down to this year’s class of 65 startups. They’ll compete for $800,000 in nondilutive funding at the end of the four-month program. “Having evaluated thousands of applicants since November, I can tell you definitively that the 2024 MedTech Innovator Cohort represents the best emerging startups around the globe,” Grand said. “We are excited to spend the next four months with our industry-leading corporate partners and industry experts, to help these entrepreneurs advance their medical device, diagnostic and digital health innovations to improve the lives of millions.” The 2024 MedTech Innovator cohort startups are: AccurKardia – New York City Acorai – Helsingborg, Sweden Akeyna – Boston Arsenal Medical – Waltham, Massachusetts Astek Diagnostics – Baltimore, Maryland ATDev – Los Angeles Aurie – Syracuse, New York Avance Innovations – London BrainSpace – Seattle Butterfly Medical – Yokneam, Israel CardioSignal – Turku, Finland Cellular Vehicles – San Mateo, California Craif – Tokyo CranioSense – Boston Cyted Health – Cambridge, United Kingdom CytoVeris – Farmington, Connecticut DiaMonTech – Berlin, Germany Dopl Technologies – Seattle Droplet IV – Copenhagen, Denmark Endo-TAGSS – Shawnee, Kansas Fasciotens – Cologne, Germany FemTherapeutics – Montreal, Canada FibriCheck – New York City Flow Medical – Chicago HealthTech Connex – Surrey BC, Canada iCE Neurosystems – Washington, D.C. INIA Biosciences – Boston Innova Vascular – Irvine, California Invicta Medical – Santa Clara, California Juniper Biomedical – Worcester, Massachusetts Laguna Tech USA – Irvine, California LaNua Medical – Dublin, Ireland LATTICE MEDICAL – Loos, France Ligence – Kaunas, Lithuania myBiometry – Boston Nanobiofab – Frederick, Maryland NANOCHON – Washington, D.C. NeuroBionics – Cambridge, Massachusetts Neuspera Medical – San Jose, California Nurami Medical – Haifa, Israel Ortho-tag – Palm Beach Gardens, Florida Orthomod – Dayton, Ohio Ozlo – Boston Paxos Medical – Minneapolis Plexaa – London Prevencio – Kirkland, Washington ReConstruct Bio – Boston Relief Cardiovascular – Costa Mesa, California Remedi – Seoul, Korea Robeauté – Paris Salvia BioElectronics – Eindhoven, The Netherlands Samay – Mountain View, California, and Medellín, Colombia SanaHeal – Cambridge, Massachusetts SmartCardia – Lausanne, Switzerland Solenic Medical – Addison, Texas Somnics Health – Redwood City, California Spiorad Medical – Dublin, Ireland Summa Therapeutics – Cambridge, Massachusetts Surgical Automations – Dallas SwiftDuct – Sakhnin, Israel Taurus Vascular – Houston The Shape Sensing Company – Austin, Texas TYBR Health – Houston Vonova – San Diego X-Bolt Orthopedics – Dublin, Ireland
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.